Danaher Corp
BMV:DHR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
North Copper Shanxi Co Ltd
SZSE:000737
|
CN |
|
E
|
Euro Holdings Bhd
KLSE:EUROSP
|
MY |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (33.3), the stock would be worth Mex$4 074.82 (22% upside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 27.3 | Mex$3 335 |
0%
|
| 3-Year Average | 33.3 | Mex$4 074.82 |
+22%
|
| 5-Year Average | 31.3 | Mex$3 821.96 |
+15%
|
| Industry Average | 29.2 | Mex$3 568.03 |
+7%
|
| Country Average | 19.6 | Mex$2 399.16 |
-28%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
Mex$159.5B
|
/ |
Jan 2026
$5.4B
|
= |
|
|
Mex$159.5B
|
/ |
Dec 2026
$7.3B
|
= |
|
|
Mex$159.5B
|
/ |
Dec 2027
$7.9B
|
= |
|
|
Mex$159.5B
|
/ |
Dec 2028
$8.5B
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Danaher Corp
BMV:DHR
|
137.5B MXN | 27.3 | 36.8 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD | 2 360.7 | 4 278.7 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
197.4B USD | 26.9 | 29 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 39.4 | 46.1 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
35.1B CHF | 26.7 | -124.9 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
294B CNY | 16 | 15.4 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
34.5B USD | 23.1 | 26.6 | |
| US |
|
Waters Corp
NYSE:WAT
|
32.9B USD | 41 | 50.5 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.8B USD | 18.2 | 22 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
27B USD | 25.3 | 30.8 | |
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
18.3B EUR | 36.1 | 67.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.6 |
| Median | 19.6 |
| 70th Percentile | 27.8 |
| Max | 1 826 183.2 |
Other Multiples
Danaher Corp
Glance View
Once upon a time, back in 1984, two brothers, Steven and Mitchell Rales, envisioned a company that would revolutionize the manufacturing sphere, setting the roots for what would become Danaher Corporation. Born from the acquisition of a real estate investment trust, they pivoted to a broader industrial manufacturing approach, aligning themselves with the then unique concept of lean manufacturing and continuous improvement – known as the Danaher Business System (DBS). This philosophy helped them transform Danaher into an assembly of high-performance companies. Over the decades, the corporation honed its focus, shedding non-core assets, and refining its portfolio to center on biotechnology, life sciences, environmental and applied solutions, and diagnostics. Through strategic acquisitions and relentless innovation, Danaher has continued to evolve, constantly reshaping itself to meet the demands of critical sectors. Today, Danaher's operations are driven by three powerful segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Its Life Sciences segment enables breakthrough discoveries that advance scientific research, healthcare, and more. Meanwhile, the Diagnostics division delivers critical tools that aid clinical laboratories and physicians in patient care, offering blood and infection analysis technologies, among others. Finally, Environmental & Applied Solutions focuses on water quality and product-identification services, crucial for maintaining health and safety standards across industries. By continually investing in innovation and focusing on operational efficiencies through DBS, Danaher not only positions itself as a leader in these sectors—it harnesses market needs into profitable solutions, ensuring its growth and stability in a competitive global market.